We are live on ! Find out more
CAM

Claret Asset Management Portfolio holdings

AUM $928M
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
AUM
$633M
AUM Growth
+$22.6M
Cap. Flow
+$12.5M
Cap. Flow %
1.98%
Top 10 Hldgs %
45.8%
Holding
357
New
21
Increased
183
Reduced
81
Closed
51

Top Buys

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$7.7M
2
PFE icon
Pfizer
PFE
+$4.75M
3
TD icon
Toronto Dominion Bank
TD
+$3.61M
4
BCE icon
BCE
BCE
+$2.99M
5
NVO
Novo Nordisk
NVO
+$2.48M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 16.95%
3 Communication Services 13.34%
4 Financials 12.69%
5 Energy 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNE icon
301
StoneCo
STNE
$2.61B
$120K 0.02%
15,100
+5,000
+50% +$50.7K
WBA
302
DELISTED
Walgreens Boots Alliance
WBA
$116K 0.02%
12,381
-1,110
-8% -$10.3K
PMN icon
303
ProMIS Neurosciences
PMN
$122M
$11K ﹤0.01%
453
APTV icon
304
Aptiv
APTV
$10.2B
-3,201
Closed -$231K
AVTR icon
305
Avantor
AVTR
$9.11B
-8,925
Closed -$231K
BLDR icon
306
Builders FirstSource
BLDR
$8.11B
-1,300
Closed -$252K
BRKR icon
307
Bruker
BRKR
$7.98B
-3,020
Closed -$209K
CACI icon
308
CACI
CACI
$13.7B
-463
Closed -$234K
CHE icon
309
Chemed
CHE
$7.19B
-364
Closed -$219K
COO icon
310
Cooper Companies
COO
$14.5B
-2,087
Closed -$230K
CPRI icon
311
Capri Holdings
CPRI
$1.69B
-6,107
Closed -$259K
CSL icon
312
Carlisle Companies
CSL
$15.4B
-475
Closed -$214K
CZR icon
313
Caesars Entertainment
CZR
$6.13B
-5,185
Closed -$216K
DHR icon
314
Danaher
DHR
$142B
-770
Closed -$214K
DNB
315
DELISTED
Dun & Bradstreet
DNB
-21,452
Closed -$247K
EXPD icon
316
Expeditors International
EXPD
$23.4B
-1,579
Closed -$207K
FBIN icon
317
Fortune Brands Innovations
FBIN
$6.12B
-2,854
Closed -$256K
FCN icon
318
FTI Consulting
FCN
$4.26B
-944
Closed -$215K
FNV icon
319
Franco-Nevada
FNV
$46.3B
-2,014
Closed -$250K
HCA icon
320
HCA Healthcare
HCA
$89B
-576
Closed -$234K
HII icon
321
Huntington Ingalls Industries
HII
$12.7B
-935
Closed -$247K
HOG icon
322
Harley-Davidson
HOG
$2.72B
-5,929
Closed -$228K
HPQ icon
323
HP
HPQ
$26.5B
-5,821
Closed -$209K
IQV icon
324
IQVIA
IQV
$38.9B
-918
Closed -$218K
IR icon
325
Ingersoll Rand
IR
$34.4B
-2,080
Closed -$204K

Similar funds

Claret Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Claret Asset Management held 357 positions worth $633M, up 3.7% from $611M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Claret Asset Management's Q4 2024 filing shows 21 new, 183 increased, 81 reduced and 51 closed positions. Its largest new stake was Indivior Pharmaceuticals: 748,486 shares worth $9.3M. The largest sale was Paramount Global Class B, an estimated $2.58M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Claret Asset Management's largest Q4 2024 buy was Indivior Pharmaceuticals: 748,486 shares worth $9.3M.
  • Claret Asset Management added most to Pfizer in Q4 2024, an estimated $4.75M increase.
  • Claret Asset Management's biggest Q4 2024 reduction was Paramount Global Class B, cutting an estimated $2.58M.
  • Claret Asset Management fully exited Primo Water Corporation in Q4 2024, selling an estimated $900K.
  • Claret Asset Management's ten largest holdings make up 46% of its $633M portfolio in Q4 2024.
  • Claret Asset Management opened 21 new positions and closed 51 in Q4 2024.
  • Claret Asset Management's portfolio value rose 3.7% quarter-over-quarter to $633M.

Based on Claret Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.